management for pharma & biotech - amazon s3 · pdf filemodelling and data analysis for...

www.americanleaders.com

EXPERT SPEAKER PANEL

CHAIRPERSON: FRANK MAKOSIEj Covance Executive Director, Operational Strategy and Planning

USMAN IqbAL, MD, MPH, MbA Sr. Medical Affairs Leader- ING, Global Medical Affairs AstraZeneca

KAREN GRAHAM, PMP Senior Director, Project Management, Oncology Portfolio Leader Covance

FRANK MAKOSIEj Executive Director, Operational Strategy and Planning Covance

SANjEEv RAMAbHADRAN Director, Project and Portfolio Management Daiichi Sankyo Pharma Development

SEAN (YONG) XUE Director, Portfolio Management – Biologics Dr. Reddy’s Laboratories

RICHARD SONNENbLICK CEO Enrich

jULIO GAGNE Executive Program Director ImmunoGen

SULTAN M. AZIZ Senior Director, Head of Capacity Management janssen Pharmaceutical Companies of johnson & johnson

DAvID TOwNSON Head, Program Office, Cell and Gene Therapies Novartis

PETER HEINRICH President & CEO PDware

CHRISTOPHER bECK VP Schedule and Resource Decision Analytics Shire

MATT MCLEOD Senior Director, Development Team Program Lead Tesaro

GRANT MORGAN SVP Portfolio Planning, Systems & Analytics bTG International

MARK MLYNARCZYK Senior Director, Portfolio Operations, Strategy & Management MedImmune

8th Project and Portfolio

Management for Pharma

& biotech

Leveraging the Catalysts of Portfolio Success

October 6 - 7, 2015 Hyatt Regency boston

Post-show report

8th Project and Portfolio Management for Pharma & biotechAnalyzing Portfolio Risk Throughout the Project Lifecycle

October 6 - 7, 2015 | boston, MA

Table of contents

Table of contents

Page 3 About the 8th annual

Page 4 Key sessions of the conference + delegate breakdown

Page 5 Sponsor and delegate list

‘The sharing of information across companies is key for the long-term health of the industry. This conference allows for a litmus test for your own company.’

vincent AgrestoSenior Project Associate, Program Management Systems

& Operations Regeneron

‘An incredibly insightful event and collection of industry thought leaders.’

Matt Killeen, PhD.,Associate Director, Portfolio Strategy and Competitive

IntelligencebioMarin

‘The American Leaders meeting provided attendees with an excellent blend of actionable ideas that can be applied across many types and sizes of organizations.’

David TownsonExecutive Director, Global Program Team Director and

Program Management Site HeadNovartis Oncology

‘Interesting cross-section of topics and stakeholders around the industry!’

Sanjeev RamabhadranDirector, Project & Portfolio Management Global Project

Management & LeadershipDaiichi Sankyo, Inc.

‘The conference was initimate and ultimately informative. I, personally, have several “ah-ha” moments that I will take back to my company.’

Grant MorganSenior Vice President, Portfolio Panning, Systems &

AnalyticsbTG International

About the 8th AnnualFor the eighth time, senior executives from the pharma and biotech industries gathered in October 2015 at the Hyatt Regency in downtown Boston for one of the longest-running American Leaders conferences. The speaker panel 8th Annual Project and Portfolio Management for Pharma and Biotech, chaired by Covance’s Executive Director, Frank Makosiej, featured senior executives from the biggest names in the industry: including companies such as AstraZeneca, Novartis or Daiichi Sankyo. The two-day program was split into interactive sessions, providing delegates with practical solutions to the biggest issues in today’s pharma PPM. Special focus was placed on strategic alignment thanks to the “Building an Action Plan” feature. After each session, delegates were dedicated space to work on implementing the newly-gained knowledge in their companies and to discuss strengths, weaknesses and limitations.During the two conference days, delegates discussed their opinions and shared their experience on portfolio risk management, decision-making, prescriptive modelling and data analysis for pharma portfolios, among other topics. When asked about their opinions on the event, this is what the attendees had to say:

The venue:This luxury Boston hotel features 30,000 square feet of elegant and flexible function space with innovative audiovisual equipment, hotel-wide Wi-Fi access and creative catering menus. With a combination of award-winning service and custom amenities, Hyatt Regency Boston is the premier hotel for business travelers.



Key sessions of the 8th Annual

There were several hot topics presented and discussed in detail at the 8th Annual Project & Portfolio Management for Pharma and Biotech. Here are some of the sessions that were met with the best feedback from this year’s delegates:

• Daiichi Sankyo’s case study on examining progression of a project’s viability at each stage of the life cycle

• Novartis presented their own tested methodology on employing micro-funding strategies to increase portfolio flexibility

• AstraZeneca illustrated evidence-based approaches to manage portfolio risk and prioritization in their breakout session

• Roundtable discussion on portfolio and resource planning integration

• Spotlight session on portfolio planning and execution

• Case study on predictive and prescriptive modeling to help drive portfolio optimization, presented by janssen & janssen

• Dedicated networking sessions with project, portfolio and resource management decision makers

job title distribution:

68% Directors/General Managers

25% Managers/Heads of Departments

7% Specialists



MEET OUR PARTNERS

SILvER SPONSORS

PDware™ is a provider of resource planning and portfolio management software. ResourceFirst™, our flagship PPM product, helps organizations improve operations through a combination of resource forecasting, capacity planning, time tracking, status reporting and financial analysis. ResourceFirst is available for cloud and on-premise installations, providing first-line managers, executives, PMOs and EPPMOs the agility to meet fluctuating work priorities, capacity and demand. PDWare customers include Medtronic, BD, Cablevision, Regeneron, SIG, Motorola,

Philips, Stryker and Tektronix.

Enrich was born out of a restless desire to help companies do more—create more game-changing technology, develop more life-saving drugs, find more opportunity. For our clients, we build transparency into the decisions that drive their business forward. The Enrich Analytics Platform (EAP) provides the enterprise computing power; our high-touch, one-on-one approach builds the custom solutions that empower clients to make strategic business

decisions—and follow through on them.

MEDIA PARTNERS







Company jobtitle Country

AbbVie Director, Project Office USA

AbbVie Assistant Director, Planning & Portfolio Support USA

Abbott Diagnostics Director, Portfolio Management USA

Acetylon Pharmaceuticals Senior Director, Program Management USA

Adamas Pharmaceuticals Senior Director USA

Adamas Pharmaceuticals Vice President USA

Aegerion Pharmaceuticals Director, Program Management USA

Aegerion Pharmaceuticals Senior Director, Program Management USA

Alexion Pharmaceuticals Project Manager USA

Alexion Pharmaceuticals Project Planner USA

Alexion Pharmaceuticals Senior Director USA

Alkermes Senior Financial Analyst Ireland

Alkermes Senior Director, Strategic Planning & Portfolio Management Ireland

Allergan Manager, Portfolio Analysis USA

Allergan Business Analytics Manager USA

Amgen Manager, Strategic Planning & Operations USA

Amgen Director, Pipeline Strategy & Portfolio Management USA

Aptalis Pharma Senior Director, Project Management USA

AstraZeneca Head, Business Operations – Neuroscience USA

Baxalta Senior Director, Business Operations – Global Project Management USA

BIND Therapeutics Project & Portfolio Professional USA

BioMarin Pharmaceuticals Senior Director USA

BioMarin Pharmaceuticals Senior Director USA

BioMarin Pharmaceuticals Associate Director USA

BioMarin Pharmaceuticals Assistant Director, Portfolio Strategy USA

Boston Scientific Senior Manager, Corporate Portfolio USA

CNRC-IRB Director Canada

Covance Director, Portfolio Management USA

Covance Senior Director, Portfolio Management USA

Covidien Manager, Strategy & Portfolio USA

Eisai Executive Director, Global Oncology Business Unit USA

Eli Lilly Advisor, Portfolio Planning USA

Emergent BioSolutions Senior Director, Scientific Services USA

Eureka Therapeutics Head USA

Genetech Global Manager, PMO, Producer, Portfolio Management USA

Genetech Cross Portfolio Governance USA

Genetech Manager, Portfolio Management, USA Oncology Pipeline & Portfolio Planning

Genetech Ophthalmology Franchise Lead, Pipeline & Portfolio Planning USA

Genzyme Manager, Portfolio & Development Operations USA

Gilead Director, Planning & Portfolio Analysis USA

Gilead Associate Director USA

Green Cross Corporation Deputy General Manager South Korea

Green Cross Corporation Manager South Korea

Grifols Head, Project Management USA

Helsinn Therapeutics Manager, Project Management & Planning USA

Impax Laboratories Senior Director, Portfolio Management USA

Impax Laboratories Associate Director, Strategic Portfolio Management USA

Integrated Project Management Business Development Executive USA

Jazz Pharmaceuticals Senior Director, Project Management USA

Johnson & Johnson Innovation Director USA

Johnson & Johnson Innovation Global Portfolio Manager USA

Juno Therapeutics Program Manager USA

Juno Therapeutics Senior Director, Program/Alliance USA

Life Technologies/Thermo Fisher Head, Program Management Office USA

MedImmune Senior Project Manager USA

Merck Associate Director USA

Millenium Pharmaceuticals, Portfolio Manager USA The Takeda Oncology Company

Millenium Pharmaceuticals, Director, Drug Development Manager USA The Takeda Oncology Company

Novartis Executive Director USA

NPS Pharmaceuticals Director, Project Management USA



NPS Pharmaceuticals Senior Director, Project Management USA

OncoMed Pharmaceutical CMC Team Leader USA

Onyx Pharmaceuticals Senior Manager USA

OvaScience Associate Manager, Program Management USA

Perrigo Director USA

Perrigo Director, Stage Gate USA

Regeneron Pharmaceuticals Director USA

Regeneron Pharmaceuticals Senior Project Associate USA

Roche Head, Strategy & Portfolio, Switzerland Pharma Reserach & Early Development

SciClone Pharmaceuticals Assistant Project Manager USA

Seattle Genetics Inc. Senior Director, Programs & Alliance Management USA

Shire Pharmaceuticals Associate Director USA

Smith and Nephew Senior Project Manager USA

Sunovion Pharmaceuticals Associate Director USA

Sunovion Pharmaceuticals Director USA

Sunovion Pharmaceuticals Senior Director USA

Takeda Pharmaceuticals Associate Director, Portfolio Management USA

Takeda Pharmaceuticals Associate Director, Global Project Management USA & Drug Development Management

Taris Biomedical Director, Program Management USA

Teva Pharmaceuticals Group General Manager USA

Vertex Pharmaceuticals R&D Program Manager USA

Vertex Pharmaceuticals Director USA

X-gen Director USA

XOMA Ltd. Senior Project Manager USA

XOMA Ltd. Associate Director USA

XOMA Ltd. Director USA

XOMA Ltd. Associate Director, Project & Alliance Management USA



management for pharma & biotech - amazon s3 · pdf filemodelling and data analysis for...

Documents